PiLeJe S.A.S., headquartered in France, is a prominent player in the health and nutrition industry, specialising in the development of innovative dietary supplements and probiotics. Founded in 1991, the company has established itself as a leader in the field, with a strong presence across Europe and beyond. With a focus on personalised health solutions, PiLeJe offers a diverse range of products, including probiotics, vitamins, and minerals, all designed to support individual well-being. Their commitment to quality and scientific research sets them apart in a competitive market, ensuring that their offerings are both effective and reliable. Recognised for their expertise, PiLeJe S.A.S. has achieved significant milestones, including numerous partnerships with healthcare professionals and institutions, solidifying their reputation as a trusted name in health and nutrition.
How does PiLeJe S.A.S.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
PiLeJe S.A.S.'s score of 16 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, PiLeJe S.A.S. has not disclosed specific carbon emissions figures in kg CO2e. However, the company has set ambitious near-term climate commitments aimed at significantly reducing its greenhouse gas emissions. PiLeJe has committed to a reduction of approximately 58.8% in absolute Scope 1 and 2 greenhouse gas emissions by the year 2034, using 2022 as the baseline year. Additionally, the company aims to reduce Scope 3 emissions by about 63.8% per million USD value added within the same timeframe. These targets are aligned with the science-based targets necessary to limit global warming to 1.5°C, demonstrating PiLeJe's commitment to addressing climate change effectively. The emissions data and targets are cascaded from PiLeJe S.A.S. as part of its corporate family relationship, indicating a structured approach to sustainability within the organisation. While specific emissions data is currently unavailable, these commitments reflect a proactive stance in the pharmaceuticals, biotechnology, and life sciences sector, where PiLeJe operates.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 4,600 | 
| Scope 2 | 11,200 | 
| Scope 3 | 1,457,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PiLeJe S.A.S. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
